LifeCodexx, Charite form research alliance against preeclampsia

LifeCodexx AG, a leading European company engaged in the development of clinically validated molecular diagnostics, and Berlin-based teaching hospital Charite […]

Diagnostika to introduce XY Clinics and Shapes Metabolic Spa in India

Diagnostika (BVI), a Dubai-based healthscience company plans to launch a series of high-end XY Clinics and Shapes Metabolic Spa in […]

Gen-Probe Panther Launched by Transasia

Transasia Bio-Medicals Ltd. has signed an exclusive distribution agreement with Gen-Probe, USA for marketing “Molecular Diagnostics Solutions” in India.

The PANTHER SystemTM

Transasia Bio-medicals Ltd., an undisputed leader in the Indian clinical diagnostics market for more than three decades, is well known for bringing innovative products and cutting edge technologies to India.

Molecular Diagnostics Point-of-Care (POC) Infectious Disease Test- Market Insight, Healthcare Practice, Frost & Sullivan

[This article was published in the March 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

At present, polymerase chain reaction (PCR) testing predominates; however, alternative technologies aimed at reducing genome complexity without PCR are anticipated to gain momentum in the coming years.